GlassScriptPhysician profile
Douglas J Kaderabek
NPI 1821097338
$1,566.12
in general payments reported to CMS, 2019-2025
22 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $106 · 2021: $104 · 2022: $95.47 · 2023: $98.33 · 2024: $303 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613 · Education: $68.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.85 |
| Education | $68.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $336.03 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acell, INC. | $169.80 | 2019 | |
| W. L. Gore & Associates, INC. | $167.28 | 2021-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $147.05 | 2019 | |
| Teleflex LLC | $137.44 | 2024 | Arrow |
| Davol INC. | $106.25 | 2019 | |
| Kerecis Limited | $72.06 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $68.84 | 2021-2023 | Integra, Omnigraft, Surgimend |
| Takeda Pharmaceuticals U.S.A., INC. | $59.41 | 2022-2024 | Gattex |
| Acera Surgical, INC. | $46.17 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $43.86 | 2022-2023 | Progrip |
| Terumo Medical Corporation | $36.51 | 2024 | Azur Cx Detachable |
| Vertex Pharmaceuticals Incorporated | $24.71 | 2025 | |
| Abbott Laboratories | $24.13 | 2019 | |
| Karl Storz Endoscopy-America | $19.30 | 2023 | Image1 X-Link |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $17.85 | 2019 | |
| Innocoll Pharmaceuticals Limited | $17.76 | 2021 | |
| Octapharma USA, INC. | $17.18 | 2025 | Fibryga |
| Heron Therapeutics, INC. | $14.76 | 2021 | |
| Sanara Medtech INC. | $14.68 | 2021 | |
| Medline Industries LP | $12.77 | 2019 | |
| Endo Pharmaceuticals INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Kaderabek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.